Home›Stocks›INM

INM — structural market context

InMed Pharmaceuticals Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 21. Each line shows the earlier value, the later value and their dates.

Price

Close $1.36 (Oct 21) vs $1.34 (Oct 20): +1.49%.

Volume

0.68× its 20-session average (40K) on Oct 21.

Includes pre- and post-market trading.

Short interest

Short interest 34K shares (settlement Sep 30) vs 16K (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 3 days with fails, largest 3K shares on Sep 25.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 5 days with fails, largest 36K shares on Sep 4.

No new publication in this window.

Insider filings (Form 4)

None recorded in this window.

INM short interest & days to cover

SHARES SHORT
34K
% OF FLOAT
0.8%
DAYS TO COVER
1.0
CHANGE VS PRIOR
+114.7%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (22d ago)

INM fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-29 · 23d272$1.36
2026-09-25 · 27d3K$1.4
2026-09-22 · 30d1K$1.38

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

INM insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 14 purchases · 0 sales

InsiderTypeSharesValueFiled
ADAR1 Capital Management, LLC · 10 percent ownerPurchase (P)1$12026-10-20
ADAR1 Capital Management, LLC · 10 percent ownerPurchase (P)1K$1K2026-10-20
ADAR1 Capital Management, LLC · 10 percent ownerPurchase (P)984$1K2026-10-15
ADAR1 Capital Management, LLC · 10 percent ownerPurchase (P)564$7502026-10-15
ADAR1 Capital Management, LLC · 10 percent ownerPurchase (P)8K$11K2026-10-15

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Frequently asked questions

What is INM's short interest?
As of the FINRA settlement date 2026-09-30, INM had 34K shares sold short — 0.8% of its float, with 1.0 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying INM?
In the last 12 months of SEC Form 4 filings, INM recorded 14 insider purchases and 0 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
Is this page telling me to buy or sell INM?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with I

IAG · IAMGold CorporationIBKR · Interactive Brokers Group, IncIBP · INSTALLED BUILDING PRODUCTS, IICL · ICL Group Ltd.IDT · IDT CorporationIDXX · IDEXX Laboratories, Inc.All I →

INM: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.